Vor Biopharma (VOR) Change in Cash (2020 - 2026)

Vor Biopharma (VOR) has 7 years of Change in Cash data on file, last reported at -$226.6 million in Q1 2026.

• Change in Cash for Q1 2026 came in at -$226.6 million, down 610.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $117.6 million (up 2213.22% YoY), and the FY2025 annual result was $312.3 million, up 517.31% from the prior year.
• Change in Cash retreated to -$226.6 million in Q1 2026 per VOR's latest filing, from $236.0 million in the prior quarter.
• Over five years, Change in Cash peaked at $236.0 million in Q4 2025 and troughed at -$226.6 million in Q1 2026.
• A 5-year average of $2.8 million and a median of -$10.2 million in 2023 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2025 and 2026: Change in Cash soared 709.66% in 2025, then slumped 610.34% in 2026.
• A 5-year view of Change in Cash shows it stood at -$3.1 million in 2022, then plunged by 337.87% to -$13.7 million in 2023, then jumped by 313.31% to $29.2 million in 2024, then soared by 709.66% to $236.0 million in 2025, then slumped by 196.01% to -$226.6 million in 2026.
• Business Quant data shows VOR's Change in Cash at -$226.6 million in Q1 2026, $236.0 million in Q4 2025, and -$32.4 million in Q3 2025.